Project Statistics: Irina S. Moreira acknowledges support by the Fundação para a Ciência e a Tecnologia (FCT) Investigator programme - IF/00578/2014 (co-financed by European Social Fund and Programa Operacional Potencial Humano), and a Marie Skłodowska-Curie Individual Fellowship MSCA-IF-2015 [MEMBRANEPROT 659826]. This work was also financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000008: BrainHealth 2020, and through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT, under project POCI-01-0145-FEDER-007440. Rita Melo acknowledges support from the FCT (FCT—SFRH/BPD/97650/2013). Jörg Schaarschmidt acknowledges support from the European H2020 e-Infrastructure grant West-Life grant no. 675858. Mikael Trellet acknowledges support from the European H2020 e-Infrastructure grants West-Life grant no. 675858 and BioExcel grant no. 675728. Panagiotis Koukos and Alexandre Bonvin acknowledge financial support from the Dutch Foundation for Scientific Research (NWO) (TOP-PUNT grant 718.015.001). Zeynep H. Gümüş acknowledges financial support from start-up funds at Icahn School of Medicine at Mount Sinai.
Geo Map
Region
#
AS - Asia, other
37
NA - North America
12
EU - Europe
1
Total
50
Country
#
CN - China
36
US - United States of America
12
DE - Germany
1
SG - Singapore
1
Total
50
City
#
Inglewood
6
New York
6
Unknown
38
Total
50
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
0 0 0 0
0 0 0 0
1 0
1
2024
2 44
2 1 0 0
0 0 0 0
0 0
49
Ever
50
Geo Map
Region | # |
---|---|
AS - Asia, other | 37 |
NA - North America | 12 |
EU - Europe | 1 |
Total | 50 |
Country | # |
---|---|
CN - China | 36 |
US - United States of America | 12 |
DE - Germany | 1 |
SG - Singapore | 1 |
Total | 50 |
City | # |
---|---|
Inglewood | 6 |
New York | 6 |
Unknown | 38 |
Total | 50 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
2024 | 2 | 44 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 |
Ever | 50 |